1-6 of 6
Peter Hoogerbrugge
Close
Sort by
Journal Articles

Potential Impact of Treatment with Inotuzumab Ozogamicin on Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Valeria Ceolin, Erica Brivio, Susan R. Rheingold, Allison Barz Leahy, Britta Julia Vormoor, Maureen M. O'Brien, Jeremy Rubinstein, Krzysztof Kalwak, Barbara De Moerloose, Elad Jacoby, Peter Bader, José L. Fuster, Franco Locatelli, Peter Hoogerbrugge, Friso Calkoen, Christian M. Zwaan
Journal: Blood
Blood (2021) 138 (Supplement 1): 3824.
https://doi.org/10.1182/blood-2021-146556
Published: 2021
Journal Articles

Fludarabine Exposure Predicts Outcome after CD19 CAR T Cell Therapy in Children and Young Adults with Acute Leukemia; An Exploratory, Observational Study

Linde Dekker, Friso Calkoen, Yilin Jiang, Hilly Blok, Maike Spoon, Rick Admiraal, Peter Hoogerbrugge, Britta Julia Vormoor, Josef Vormoor, C. Michel Zwaan, Henk Visscher, Marc Bierings, Marieke Van Der Vlugt, Harm Van Tinteren, A. Laura Nijstad, Kim Van Der Elst, Alwin D. R. Huitema, Rob Pieters, Caroline Lindemans, Stefan Nierkens
Journal: Blood
Blood (2021) 138 (Supplement 1): 3871.
https://doi.org/10.1182/blood-2021-146450
Published: 2021
Journal Articles

A CRISPR/Cas9 Based Kinome Screen Identifies Bruton Tyrosine Kinase (BTK) As an Important Determinant of Asparaginase Treatment Response in Acute Lymphoblastic Leukemia

Miriam Butler, MSc, Laurens Van Der Meer, PhD, Jiangyan Yu, Silvia Jenni, PhD, Maria Pamela Dobay, PhD, Peter Hoogerbrugge, MD, Beat Bornhauser, PhD, Jean-Pierre Bourquin, MD PhD, Roland P. Kuiper, PhD, Frank van Leeuwen, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 34.
https://doi.org/10.1182/blood.V130.Suppl_1.34.34
Published: 2017
Journal Articles

Mitoxantrone Improves the Outcome of Children with Central Nervous System (CNS) Involvement at First Relapse of Acute Lymphoblastic Leukemia (ALL)-Results of the International ALLR3 Study

Ashish Narayan Masurekar, Catriona Anne Parker, BSc, MSc, PhD, Satarupa Choudhuri, Carly Leighton, Jeremy Hancock, Rosemary Sutton, Anthony V. Moorman, PhD, Phil Ancliff, Mary Morgan, MD, Nicholas Goulden, Nina Green, Tamas Revesz, MD, PhD, FRACP, Peter Hoogerbrugge, MD, PhD, Philip Darbyshire, Sharon Love, Vaskar Saha
Journal: Blood
Blood (2010) 116 (21): 3303.
https://doi.org/10.1182/blood.V116.21.3303.3303
Published: 2010
Journal Articles

A Key Role for Tumor Suppressor BTG1 In the Regulation of Metabolic Stress Responses: Implications for Asparaginase Resistance In Pediatric Acute Lymphoblastic Leukemia.

Laurens van der Meer, Marloes Levers, Liesbeth van Emst, Joost C. van Galen, PhD, Ad Geurts van Kessel, PhD, Roland P. Kuiper, PhD, Peter Hoogerbrugge, MD, PhD, Frank N. van Leeuwen, PhD
Journal: Blood
Blood (2010) 116 (21): 1028.
https://doi.org/10.1182/blood.V116.21.1028.1028
Published: 2010
Journal Articles

Toxicity of ALL Treatment in Adolescents as Compared to That in Younger Children.

Tim Dijkema, MD, Jacqueline GrootLoonen, MD, PhD, Jos Bokkerink, MD, PhD, Peter Hoogerbrugge, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4432.
https://doi.org/10.1182/blood.V104.11.4432.4432
Published: 2004